Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin Prophylaxis in Azacitidine Treated MDS
NCT02981615Phase 3Completed
- Sponsor
- Sheba Medical Center
- Start
- Aug 2017
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bacterial infection comparing Levofloxacin Arm with Placebo Arm (2 arms). Primary endpoint: Febrile episodes (fever >38.0c) rate at 6 months. Started Aug 2017; status: completed.
02
Drugs
levofloxacin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT02981615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02981615.